Imigran Injection/Subject - syringes may have needles protruding from the needle shield

(GlaxoSmithKline UK) Remaining stocks of the affected batch should be quarantined and returned to the original supplier for credit – class 2 action within 48 hours. (EL (13)A/26)

29 October 2013

Class 2 medicines recall

Action within 48 hours

Pharmacy, wholesaler and clinic-level recall

MDR 77-10/13

Product details

Glaxo Wellcome UK Limited trading as GlaxoSmithKline UK

Imigran Injection/Subject

(Sumatriptan Succinate)

PL 10949/0113

Alert details

Description   Batch number   Expiry date   Pack size   First distributed
Imigran Inj/Subject Treatment   C640404   15 May 2015   2x0.5ml   19 September 2013
Imigran Inj/Subject Refill   C639899   4 June 2015   2x0.5ml   2 September 2013
Imigran Inj/Subject Treatment   C638748   4 June 2015   2x0.5ml   23 August 2013
Imigran Inj/Subject Refill   C638737   4 June 2015   2x0.5ml   9 September 2013
Imigran Inj/Subject Treatment   C636954   4 June 2015   2x0.5ml   14 August 2013

Glaxo Wellcome UK Limited trading as GlaxoSmithKline UK are recalling the above batches of Imigran Injection/Subject to pharmacy, clinic and wholesaler level as a small number of syringes may have needles protruding from the needle shield.

The risk to the patient of finding an affected syringe is extremely low; the implication of patient exposure to a syringe with a protruding needle is the potential risk of infection.

Remaining stocks of the affected batch should be quarantined and returned to the original supplier for credit.  For enquiries relating to stock returns please contact your original supplier.

For medical information enquiries please contact GSK on 0800 221441 or email customercontactuk@gsk.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.

Download documents

Help us improve GOV.UK

Don’t include personal or financial information, eg your National Insurance number or credit card details.